Post Partum Depression
Conditions
Interventions
The subjects will be allocated in oxytocin-placebo groups (Gope placebo-oxytocin (GPO) remain the subject and the researcher 'blind' on the substance administered until the end of the experiment. Volu
Drug
Sponsors
Faculda de Medicina de Ribeirão Preto
Mariana Fortunata Donadon
Conselho Nacional de Desenvolvimento Científico e Tecnologico
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Check shall be the initial inclusion criteria (age above 18 years, post-pregnancy postpartum (20-45 days after the baby's birth), number of previous pregnancies) and those that meet the criteria will be invited to participate in the study.
Exclusion criteria
Exclusion criteria: mothers with absence of diagnosis of depression post partum; age under 18 post-pregnancy than in the postpartum period (20-45 days after the baby's birth; mothers with birth complications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: Improvement in the recognition of facial expressions of emotion, evaluated through two different tasks (computer and card). Will be evaluated the number of hits, the reaction time and the intensity of emotion. To check the outcome will be used statistical test group compared with a value of p is greater than 0:05. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome: mothers with postpartum depression and early emotional trauma present higher losses in the recognition of facial expressions of emotion. The presence / absence of early traumas emocionas will be assessed through a scale of self-assessment (type yes / no) and differences between groups through statistical test (significance p <0.05) | — |
Countries
Brazil
Contacts
Public ContactMariana donadon
Faculda de Medicina de Ribeirão Preto
Outcome results
None listed